Pharming Group N.V.PHARNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank77
3Y CAGR-22.9%
5Y CAGR+85.4%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-22.9%/yr
Quarterly compound
5Y CAGR
+85.4%/yr
Recent deceleration
Percentile
P77
Within normal range
vs 5Y Ago
21.9x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 157.78% |
| Q2 2025 | 20841.07% |
| Q1 2025 | -100.61% |
| Q4 2024 | -1.54% |
| Q3 2024 | 169.76% |
| Q2 2024 | -73.25% |
| Q1 2024 | -168.71% |
| Q4 2023 | 232.72% |
| Q3 2023 | 132.53% |
| Q2 2023 | 54.82% |
| Q1 2023 | -529.18% |
| Q4 2022 | -57.17% |
| Q3 2022 | 344.48% |
| Q2 2022 | 1102.99% |
| Q1 2022 | -98.08% |
| Q4 2021 | 0.00% |
| Q2 2021 | 35.07% |
| Q1 2021 | -80.08% |
| Q4 2020 | 52.80% |
| Q3 2020 | -34.31% |
| Q2 2020 | 7.21% |
| Q1 2020 | 20.56% |
| Q4 2019 | 418.23% |
| Q3 2019 | -80.46% |
| Q2 2019 | 44.71% |
| Q1 2019 | -32.15% |
| Q4 2018 | -6.18% |
| Q3 2018 | 54.66% |
| Q2 2018 | 586.80% |
| Q1 2018 | -107.55% |
| Q4 2017 | 88.74% |
| Q3 2017 | 1703.83% |
| Q2 2017 | 83.96% |
| Q1 2017 | -356.12% |
| Q4 2016 | 158.26% |
| Q3 2016 | 39.25% |
| Q2 2016 | -88.61% |
| Q1 2016 | -4.13% |
| Q4 2015 | 33.36% |
| Q3 2015 | 11.23% |